ArticleCureus2026
Functional Changes in the Thyroid Gland Following Bariatric Surgery.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionBariatric surgery, also known as metabolic surgery, is known to improve the metabolic profile of morbidly obese patients in many aspects, thereby improving their quality of life. Obesity is typically associated with subtle changes in thyroid homeostasis. Bariatric procedures, particularly sleeve gastrectomy and Roux-en-Y gastric bypass, are associated with reductions in thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), and total triiodothyronine (TT3) levels during the first postoperative year. This study aimed to evaluate the impact of bariatric surgery on thyroid function and thyroxine requirements in patients with and without pre-existing hypothyroidism.
methodsThis retrospective cross-sectional study was conducted at the Department of General Surgery, Dubai Health, United Arab Emirates. All patients who underwent bariatric surgery between September 2017 and December 2023 were included. Patients were divided into two groups: (1) those with preoperative hypothyroidism controlled on thyroxine therapy and (2) those with normal thyroid function. Patients with hyperthyroidism or a history of total thyroidectomy were excluded. Thyroid function tests and thyroxine requirements were evaluated preoperatively and at one- and two-year follow-up.
resultsA total of 853 patients were included (mean age: 34.4 ± 11.0 years; 71.1% female). Sleeve gastrectomy accounted for 35.3% of procedures, Roux-en-Y gastric bypass for 55.9%, and redo-/mini-gastric bypass for 8.8%. All procedures resulted in significant weight loss at one and two years postoperatively (p < 0.001). Baseline thyroid function was within reference ranges, and postoperative TSH and free T4 levels remained stable. Among the 46 hypothyroid patients receiving thyroxine therapy, only a small proportion required dose adjustments, with no significant association with the type of surgery (χ²(6) = 3.35, p = 0.763). No correlation was found between BMI reduction and changes in thyroid hormone levels.
conclusionThis study found no significant association between weight loss following bariatric surgery and changes in thyroid hormone function. No significant alterations in thyroxine requirements were observed. Larger multicenter studies with follow-up beyond two years are needed to further evaluate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.